The Nation - News from March 24, 1985
Lawyers for plaintiffs in the Bendectin lawsuit against Merrell Dow Pharmaceuticals asked a federal judge for a new trial, citing what they said were 43 errors made by the pharmaceutical company’s lawyers. More than 1,100 plaintiffs nationwide have charged that Bendectin, an anti-nausea drug used to treat pregnant women, caused birth defects in their children. On March 13, a U.S. District Court jury found in favor of Merrell Dow, the Cincinnati-based company that manufactured the drug until 1983.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
